Iloprost for sickle cell pain crisis
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests a medicine called iloprost, given through an IV, to see if it can help relieve the pain of a sickle cell crisis. If you are hospitalized for a crisis, this treatment may speed up your recovery and reduce pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Diagnosed with sickle cell disease (any type)
- Currently in the hospital for a pain crisis that requires IV pain medicine
- Have been hospitalized for less than 36 hours
- Cannot be pregnant or breastfeeding, and must use birth control if you could become pregnant
- Not be an active smoker
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving high-flow oxygen can help treat a painful sickle cell “vaso-occlusive crisis” (VOC) and lower the risk of a serious lung complication. You may be eligible if you’re an adult with sickle cell disease experiencing an opioid-requiring pain flare and have higher risk for lung trouble.
This trial tests an intravenous medicine called L-citrulline for young people with sickle cell disease who are in the emergency department for a painful crisis (vaso-occlusive crisis). It aims to see if it can ease the pain and help you recover faster.
This trial compares different ways to manage sickle cell pain crises in the hospital, using a flexible 'platform' design to test combinations of pain medicines. It aims to find the safest and most effective approach to reduce pain and improve recovery.
This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.
This trial tests whether crizanlizumab can reduce painful sickle cell crises (called vaso-occlusive crises or VOCs) in people with sickle cell disease who have frequent crises. It may be an option for those who still have crises despite current treatments.
This study tests an investigational oral pill called etavopivat that may help reduce pain crises in people with sickle cell disease. You may qualify if you have frequent pain crises and are not on regular blood transfusions.
Hear when a new Vaso-Occlusive Crises trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.